The types classification within the EMI Filters for Medical Device market distinguishes three core architectures, each contributing uniquely to the overall market volume. Passive LC filters dominate with an estimated 55 % share, favored for their simplicity, low cost, and proven effectiveness in attenuating narrow‑band interference across a wide frequency spectrum. Passive RC filters follow at 30 %, primarily employed in low‑frequency circuits where voltage ripple suppression is paramount, offering compact form factors suitable for miniaturized medical implants. Active filters, representing roughly 10 % of the market, integrate amplifying stages to achieve higher attenuation levels and adaptive tuning, increasingly adopted in high‑performance imaging and therapeutic platforms that demand precise EMC compliance. The remaining 5 % consists of hybrid solutions, which combine passive and active elements to balance cost, size, and performance constraints across diverse device families. This type‑based market taxonomy elucidates how engineering trade‑offs drive procurement decisions, thereby influencing the aggregate market size.